FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate | .75 mg/1 mL; 10 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Timolol Maleate; Bimatoprost | 5 mg/1 mL; .1 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine | 5 mg/1 mL; 20 mg/1 mL; 1.5 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate; Bimatoprost | 5 mg/1 mL; 20 mg/1 mL; 1.5 mg/1 mL; .1 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Vancomycin Hydrochloride | 50 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Vancomycin Hydrochloride | 25 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Vancomycin Hydrochloride; Tobramycin | 50 mg/1 mL; 15 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Vancomycin Hydrochloride; Tobramycin | 25 mg/1 mL; 10 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Cyclopentolate Hydrochloride; Phenylephrine Hydrochloride; Tropicamide | 10 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Cyclosporine | 1 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 1 mg/1 mL; .5 mg/1 mL; .4 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dorzolamide Hydrochloride | 20 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dorzolamide Hydrochloride; Bimatoprost; Timolol Maleate | 20 mg/1 mL; .1 mg/1 mL; 5 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dorzolamide Hydrochloride; Brimonidine | 20 mg/1 mL; 1.5 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 7.5 mg/1 mL; .25 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Atropine Sulfate | .1 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | .8 mg/.8 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Bromfenac Sodium | 5 mg/1 mL; .75 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Atropine Sulfate | .25 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | .6 mg/.6 mL; 9 mg/.6 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Atropine Sulfate | .5 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate | 1 mg/1 mL; 10 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Azithromycin Dihydrate | 10 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2 mg/.165 g; 25 mg/.165 g; 3 mg/.165 g | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-1 | valid | 2026-10-17 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5340 | 71139-5340-2 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/200 mL; 400 ug/200 mL | 2025-1 | valid | 2026-10-17 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5340 | 71139-5340-4 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/200 mL; 400 ug/200 mL | 2025-1 | valid | 2026-10-17 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5355 | 71139-5355-2 | Sugammadex | 200 mg/2 mL | 2025-1 | valid | 2026-10-17 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5355 | 71139-5355-1 | Sugammadex | 200 mg/2 mL | 2025-1 | valid | 2026-10-17 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0190 | 71139-0190-1 | "vasopressin, Unspecified" | 2 U/2 mL | 2025-1 | valid | 2026-10-17 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2500 ug/50 mL | 2025-1 | valid | 2026-10-17 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0012 | 71139-0012-1 | Oxytocin | 30 U/500 mL | 2025-1 | valid | 2026-10-17 | ||
| "McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing Solutions(134632103)" | 67157-002 | 67157-002-15 | Alpha Lipoic Acid | 40 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing Solutions(134632103)" | 67157-135 | 67157-135-30 | Glutathione | 200 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing Solutions(134632103)" | 67157-006 | 67157-006-30 | Methylcobalamin | 5 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-987 | 69374-987-50 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-984 | 69374-984-10 | Sodium Bicarbonate; Lidocaine Hydrochloride; Potassium Chloride | 1.04 g/1 mL; 123 mg/1 mL; 2.19 g/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-335 | 69374-335-50 | Sodium Chloride | 9 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-334 | 69374-334-50 | Sodium Chloride | 9 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-330 | 69374-330-05 | Albuterol | 5 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-308 | 69374-308-05 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 5000 g/1 mL; 5000 g/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-902 | 69374-902-35 | Neostigmine Methylsulfate | 1 mg/1 mL | 2025-1 | valid | 2026-10-17 |